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Images in cardiovascular ultrasound
A 64-year-old Japanese man was referred to our hospital
because of palpitation. An electrocardiogram revealed first-
degree atrioventricular block without ST-T change. An
echocardiography showed structural abnormality into the
left ventricular outflow tract (LVOT), mitral valve leaflet
cleft without mitral regurgitation, and single papillary
muscle (loss of posterior papillary muscle) (Figs. 1, 2). A
structural abnormality was attached between the base of the
intraventricular septum and anterior mitral leaflet, which
was mobile in the cardiac cycle. Peak velocity of LVOT
was 1.7 m/s. Cardiac systolic function was normal. We
diagnosed accessory mitral valve tissue (AMVT) with
mitral complex structural abnormality (mitral valve leaflet
cleft and single papillary muscle).
AMVT is a rare congenital cardiac malformation. The
age of AMVT diagnosis ranged from newborns to 77 years
[1]. It was reported that the incidence of AMVT in adults
was 1/26,000 echocardiogram [2]. Although the exact
embryologicmechanism of AMVT formation is not clear, it
may stem from the abnormal or incomplete separation of
the mitral valve from the endocardial cushions [3]. AMVT
is associated with other congenital intracardiac and vas-
cular malformations such as ventricular septal defect [4]. In
this case, we found AMVT with a combination of mitral
valve leaflet cleft and single papillary muscle (loss of
posterior papillary muscle). To our knowledge, this is the
first reported case of AMVT with a combination of mitral
valve leaflet cleft and single papillary muscle.
An echocardiography can be considered the gold stan-
dard modality for the diagnosis of AMVT with other car-
diac abnormality.
Although single papillary muscle usually combined the
parachute mitral valve, the parachute mitral valve was not
observed in this case. The majority of patients with AMVT
have no symptoms, such as chest pain, palpitation, and
syncope [5–7]. However, this patient was referred to our
hospital because of palpitation. No arrhythmia was ob-
served in electrocardiogram monitoring.
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Fig. 1 a Transthoracic echocardiography in the apical long-axis view
shows accessory mitral valve tissue (AMVT) (arrow) into the left
ventricular outflow tract (LVOT). LV left ventricle, LA left atrium, Ao
aorta, AMVT accessory mitral valve tissue. b Transthoracic echocar-
diography in the parasternal short-axis view in diastole shows mitral
valve leaflet cleft and AMVT (arrow) attached from the base of the
intraventricular septum to anterior mitral leaflet. AML anterior mitral
leaflet, PML posterior mitral leaflet. c Transthoracic echocardiogra-
phy in the parasternal short-axis view in systole. d Transthoracic
echocardiography in the parasternal short-axis view shows single
papillary muscle (loss of posterior papillary muscle)
Fig. 2 a Three-dimensional transesophageal echocardiography
shows in diastole show mitral valve leaflet cleft and AMVT (arrow)
attached from base of intraventricular septum to anterior mitral
leaflet. b Three-dimensional transesophageal echocardiography in the
long-axis view shows accessory mitral valve tissue (AMVT) (arrow)
into the LVOT
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